An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving
Saved in:
| Main Authors: | Andrea Carta, Martina Tedesco, Federica Mescia, Chiara Manenti, Bernardo Lucca, Federica Verzeletti, Alice Guerini, Federica Gaia Terni, Roberto Zubani, Simona Guerini, Brunella Valzorio, Guido Jeannin, Orsola Carli, Corrado Camerini, Stefano Possenti, Paola Gaggia, Federico Alberici |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-02-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024923015978 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of the calcimimetic agent Etelcalcetide in the treatment of secondary hyperparathyroidism in hemodialysis patients
by: DENG Hua, et al.
Published: (2019-01-01) -
Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation
by: Philippe Delaey, et al.
Published: (2024-07-01) -
Management of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
by: Pringgodigdo Nugroho
Published: (2021-12-01) -
Real-world safety profile of etelcalcetide in dialysis-related secondary hyperparathyroidism: a pharmacovigilance analysis of FAERS data
by: Cong Zou, et al.
Published: (2025-12-01) -
Calcimimetics and Vascular Calcification
by: Avinash Chandu, et al.
Published: (2025-06-01)